Amicus Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 5.98, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Amicus Therapeutics Inc in Dec 31 2025 quarter, has decreased to 61 days, compared to 63 days, in the Sep 30 2025 quarter.

If we take a look into Healthcare sector 107 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 921, from overall ranking in the third quarter 2025 at 1367.

What is Receivable Turnover Ratio?
What is Amicus Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FOLD Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	14.05 %	16.07 %	24.27 %	15.56 %	15.37 %
Y / Y Revenue Change	23.72 %	19.37 %	22.2 %	13.4 %	30.09 %
Receivable Turnover Ratio (TTM)	5.98	5.84	5.8	5.82	5.84
FOLD's Total Ranking	# 921	# 1367	# 1825	# 1766	# 1740
Accounts Receivable average collection period days	61	62	63	63	62
Seq. Receivable Change	1.29 %	7.55 %	19.84 %	-12.64 %	3.09 %
Seq. Revenue Change	9.86 %	9.14 %	24.02 %	-16.8 %	6 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 25
Healthcare Sector	# 108
Overall Market	# 921

Receivable Turnover Ratio Statistics
High	Average	Low
0.74	0.37	0.03
(Dec 31 2025)

FOLD Company Profile • Back to FOLD Efficiency Comparisons • Compare FOLD Receivables Turnover Ratio to its Competitors

Financial Statements
Amicus Therapeutics Inc 's Accounts Receivable	$ 115 Millions	Visit FOLD's Balance sheet
Amicus Therapeutics Inc 's Sales TTM	$ 633 Millions	Visit FOLD's Income Statement
Sources of FOLD's Revenues		Visit FOLD's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FOLD's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FOLD's Growth Rates	FOLD's Roa	FOLD's Inventory Turnover Ratio	FOLD's Dividend Comparisons
FOLD's Profitability Ratios	FOLD's Roi	FOLD's Asset Turnover Ratio	FOLD's Dividend Growth
FOLD's Valuation Ratios	FOLD's Roe	FOLD's Financial Strength Ratios	FOLD's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Precipio inc	15.02	$ 24.049 Millions	$ 1.601 Millions
Qhslab Inc	14.47	$ 2.692 Millions	$ 0.186 Millions
Arbutus Biopharma Corp	14.04	$ 14.083 Millions	$ 1.003 Millions
Sutro Biopharma Inc	13.92	$ 102.484 Millions	$ 7.365 Millions
Aim Immunotech Inc	13.54	$ 0.088 Millions	$ 0.007 Millions
Amneal Pharmaceuticals Inc	13.44	$ 3,018.308 Millions	$ 224.629 Millions
Inmed Pharmaceuticals Inc	13.26	$ 4.507 Millions	$ 0.340 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.18	$ 52.149 Millions	$ 3.957 Millions
Nexgel Inc	13.17	$ 10.509 Millions	$ 0.798 Millions
China Pharma Holdings Inc	13.14	$ 4.144 Millions	$ 0.315 Millions
Milestone Scientific Inc	12.98	$ 8.408 Millions	$ 0.648 Millions
Escalon Medical Corp	12.93	$ 12.311 Millions	$ 0.952 Millions
Dbv Technologies S a	12.63	$ 5.683 Millions	$ 0.450 Millions
Mannkind Corporation	12.49	$ 348.966 Millions	$ 27.948 Millions
Safe Pro Group Inc	12.46	$ 0.607 Millions	$ 0.049 Millions
Icu Medical Inc	12.35	$ 2,231.262 Millions	$ 180.620 Millions
Ensysce Biosciences Inc	12.27	$ 5.067 Millions	$ 0.413 Millions
Neuroone Medical Technologies Corp	12.24	$ 8.716 Millions	$ 0.712 Millions
Skinhealth Systems Inc	12.08	$ 300.364 Millions	$ 24.872 Millions
Ptc Therapeutics inc	11.92	$ 1,730.655 Millions	$ 145.207 Millions
Corcept Therapeutics Inc	11.91	$ 761.407 Millions	$ 63.950 Millions
Option Care Health Inc	11.86	$ 5,648.895 Millions	$ 476.492 Millions
Cytokinetics Incorporated	11.74	$ 88.039 Millions	$ 7.499 Millions
Teladoc Health Inc	11.74	$ 2,529.977 Millions	$ 215.496 Millions
Lifestance Health Group Inc	11.71	$ 1,424.285 Millions	$ 121.659 Millions
Chemed Corporation	11.65	$ 2,529.978 Millions	$ 217.224 Millions
Orthofix Medical Inc	11.58	$ 822.017 Millions	$ 71.016 Millions
Lucid Diagnostics Inc	11.57	$ 4.706 Millions	$ 0.407 Millions
Integrated Biopharma Inc	11.30	$ 51.068 Millions	$ 4.521 Millions

Date modified: 2026-06-22T14:32:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.